SlideShare uma empresa Scribd logo
1 de 5
Baixar para ler offline
Biobanking
 Conference 2010
  Analysing the trends and understanding the complexities of biobanking

4th - 5th February 2010, Earls Court Conference Centre, London, UK                                    BOOK NOW!

 Key Speakers
 Julie Corfield, R&D Site Biobank Head, Astrazeneca

 Anne Bahr, R&D Data Privacy Coordinator, Sanofi-Aventis

 Dr. Maria Krestyaninova, Biomedical Informatics Coordinator, European Bioinformatics Institute

 Dr. Kristian Unger, Research Associate Division of Investigative Science, Imperial College London

 Kate Rolfvondenbaumen, Regulation Manager, Human Tissue Authority

 Alastair Kent, Director, Genetic Interest Group

 Dr. Alison Parry-Jones, Manager, Wales Cancer Bank

 Marc Martens, Partner, Bird & Bird LLP

 Morag McFarlane, Chief Scientific Officer, Tissue Solutions

 Dr. John Cason, Senior (Non-Clinical) Lecturer in Virology, King’s College London School of Medicine

 Dr. Michael D. Leek, Vice President, The Weinberg Group

 Dr. Martin Frey, Senior Product Manager Storage Technologies, Hamilton Bonaduz

 Dr. Ulla Krüppel, International Marketing, Chemagen Biopolymer-Technologie

 Jonathan Horan, Product Manager, Vitro



  Silver Sponsor                                                             Associate Sponsors   R




                                 Driving the Industry Forward | www.futurepharmaus.com                      Organised By
Media Partners



      To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/biobanking
Conference Introduction
                                                                                               Biobanking Conference 2010
                                                                                       4th - 5th February 2010, London, UK

                                                                                          Silver Sponsor:
Dear Colleague,                                                                                                         NEXUS	Biosystems	is	a	worldwide	developer	of	enabling	technologies	and	
                                                                                                                        automation	systems	for	life	science	research.	Products	include	the	Universal	
	 	 iobanking	is	changing	rapidly.	Biobanks	are	playing	a	vital	role	in	the	today’s	
  B                                                                                                                     Store,	Universal	LabStore,	and	Universal	BioStore	family	of	automated	-20C	
  research	and	development	in	the	fields	of	drug	discovery	and	bioscience.	The	           and	-80C	sample	storage	and	retrieval	systems,	the	Aurora	Biotechnologies	line	of	high	performance	
  biobanking	sector	has	expanded	at	a	tremendous	rate	in	recent	years,	and	has	           microplates,	and	the	XPeel,	a	high	throughput	plate	seal	removal	system.
  also	been	facing	many	legal,	financial,	ethical,	scientific	challenges.                 For further information please visit: www.nexusbio.com
	 	 isiongain	is	happy	to	announce	its	inaugural	Biobanking	Conference	which	
  V                                                                                       Associate Sponsors:
  will	examine	major	trends	in	the	biobanking	industry	and	its	changing	scope.	By	
  attending	Visiongain’s	Biobanking	conference	delegates	will	gain	an	in-depth	
  understanding	 of	 the	 emerging	 opportunities,	 challenges	 and	 advancements	
  made	in	the	field	of	biobanking.	                                                       For further information please visit www.bio-e-bank.com


Why Attend?
                                                                                          For further information please visit www.thermofisher.com
Key benefits                                                                                                For	almost	50	years	HAMILTON	products	have	successfully	served	researchers	in	
                                                                                                            laboratories	all	over	the	world.	A	long	history	of	successful	products	began	in	1947	with	
	 •	Assess	the	increasing	need	for	developing	biobanks	                                                     the	development	of	the	MICROLAB®	syringe	by	the	company’s	founder.	The	commitment	
                                                                                                                 R




                                                                                                            to	precision,	accuracy	and	quality	has	earned	HAMILTON	high	customer	satisfaction.	With	
	 •	Understand	the	ethical	and	regulatory	issues	                                         the	MICROLAB®	STAR	workstation,	HAMILTON	has	again	achieved	technological	leadership.	In	addition	to	this	
                                                                                          open	DNA	extraction	platform,	HAMILTON	offers	modular	automated	storage	solutions	with	the	ASM	-20°C	
	 •	Implement	strategies	to	develop	a	cost-effective	biobank	                             system	and	the	SAM	-80°C.	From	sample	preparation	to	storage:	One	solution	from	the	technology	leader.
	 •	Examine	the	importance	of	patient	involvement	in	biobank	projects	                    For further information please visit www.hamiltonrobotics.com

	 •	Learn	about	data	protection	and	quality	management	in	biobanking	                     Media Partners:
                                                                                                                  PharmiWeb.com	is	the	leading	industry-sponsored	portal	for	the	
	 •	Discuss	most	acute	and	challenging	scientific	and	policy	related	matters	                                     pharmaceutical	sector.	Supported	by	most	of	the	leading	pharmaceutical	
                                                                                                                  corporations,	PharmiWeb.com	provides	dynamic	real-time	news,	features,	
	 •		 eize	 this	 opportunity	 to	 network	 with	 leaders	 from	 pharma-biotech,	
    S                                                                                     events	listings	and	international	jobs	to	industry	professionals	across	Europe	and	the	US.
    healthcare	and	regulatory	agencies	                                                   For further information please email: corporate@pharmiweb.com
                                                                                                                   BIOTECHNOLOGY	EUROPE	is	owned	by	BIOTECHNOLOGY	WORLD.	
	 I	look	forward	to	meeting	you	at	the	conference	                                                                 It	is	based	and	located	in	Warsaw,	Poland.	Biotechnology	World	was	
	 Best	regards	                                                                           founded	in	2007	to	provide	the	world’s	biotech	and	pharma	information	and	market	to	
                                                                                          make	it	universally	accessible	and	useful	for	scientific	and	business	processes.		Its	first	step	to	
                                                                                          fulfilling	that	mission	was	building	the	BIOTECHNOLOGY	EUROPE	platform	that	will	allow	a	
	                                                                                         quick	spread	of	information	in	different	channels.	BIOTECHNOLOGY	EUROPE	offers	companies	
                                                                                          completed	internet	public	relations,	publication	and	marketing	solutions.		One	of	the	mains	
                                                                                          goals	of	BIOTECHNOLOGY	EUROPE	is	to	integrate	the	Biotech	and	Pharma	Sector	in	Europe	to	
     Pranita Nangia                                                                       global	biotechnology,	pharmaceutical	and	life	science	activities.
     Conference Producer                                                                  For further information please visit www.biotechnology-europe.com
                                                                                                                 Future	Pharmaceuticals	has	forged	powerful	relationships	with	key	
                                                                                                 Driving the Industry Forward | www.futurepharmaus.com




                                                                                                                 industry	leaders	to	provide	a	platform	for	successful	brand	recognition,	
                                                                                          and	for	senior	decision-makers	to	have	the	means	to	procure	and	plan	implementation	
                                                                                          strategies	based	on	the	topics	covered.	Positioned	to	be	an	authoritative	resource	within	top	
    Who should attend?                                                                    pharma	companies	as	well	as	small,	specialty,	and	biotech,	Future	Pharmaceuticals	magazine	
                                                                                          is	geared	to	create	a	deep	penetration	into	a	highly	targeted	and	responsive	audience,	bridging	
    VPs, Directors, Heads, Managers of:                                                   the	gap	between	the	industries’	top	issues	and	the	solutions	top-tier	vendors	can	provide.
    • Biobanks                                                                            For further information please visit: www.futurepharmaus.com
    • Tissue bank                                                                                                                                        InPharm	is	the	online	platform	for	exclusive	pharmaceutical	news,	
    • Biorepository                                                                                                                                      comment,	contracts,	services,	jobs	and	events	and	is	home	to	
    • Molecular Diagnostics                                                                                                                              InPharmjobs.com,	Pharmafile	and	Pharmafocus.
    • Clinical Genetics, Pathology
    • Histopathology                                                                      For further information please visit: www.In-Pharm.com
    • Medical Genomics                                                                                           ‘Pharma	Connections	Worldwide®	is	the	leading	professional	
    • Non-clinical Biosample                                                                                     business	networking	website	focused	in	the	Pharmaceutical,	
    • Data Privacy Office                                                                                        Biotechnology	and	Life	Sciences	research	industry.	Our	goal	is	to	
    • Health Science Policy                                                               provide	a	conduit	for	delivery	of	premiere	content	coupled	with	the	right	clientele	in	order	to	
    • Scientific and Quality                                                              facilitate	business	development	opportunities	among	industry	professionals	responsible	for	
    • Toxicology, Clinical chemistry                                                      making	key	decisions	in	a	global	marketplace.	‘
    • Laboratory and Inventory                                                            For further information please visit: www.pharmaconnections.com
    • R&D
    • Quality Control
    • Pharmacogenomics
    • Procurement and Strategic Sourcing                                                 Sponsorship and exhibition opportunities:
    • Strategic Outsourcing                                                              This	 event	 offers	 a	 unique	 opportunity	 to	 meet	 and	 do	 business	 with	 some	
    • Clinical Research
    • Translational Medicine                                                             of	the	key	players	in	the	pharmaceutical	and	biotech	industries.	If	you	have	a	
    • Personalized Medicine,                                                             service	or	product	to	promote,	you	can	do	so	at	this	event	by:	
    • Bioanalytical Chemistry                                                            •	Hosting	a	networking	drinks	reception	
    • Clinical trials and Non-clinical R & D
    • Pharmacogenomics                                                                   •	Taking	an	exhibition	space	at	the	conference	
    • Proteomics                                                                         •	Advertising	in	the	delegate	documentation	pack	
    • Personalised medicine                                                              •	Providing	branded	bags,	pens,	gifts,	etc.
    • Business development
    • Strategic alliances                                                                If	 you	 would	 like	 more	 information	 on	 the	 range	 of	 sponsorship	 or	 exhibition	
                                                                                         possibilities	for	visiongain's	Biobanking	Conference	2010,	please	contact	us:
    Others:                                                                              Christopher Clegg, +44 (0)20 7549 9943
    • Consultants& Academics                                                             christopher.clegg@visiongainglobal.com
    • Regulatory bodies
    • Researchers                                                                        Ronald Magali, +44 (0)20 7549 9934
                                                                                         ronald.magali@visiongainglobal.com
Day 1
                                                                                           Biobanking Conference 2010
                                                                                Thursday 4th February 2010, London, UK


09:30   Registration and refreshments                                                             14:50         Challenges for the governance of biobanks
                                                                                                  	             •		 he	mixed	message	of	regulatory	bodies:	‘dangers’	and	‘profits’
                                                                                                                  T
10:00   Opening address from the chair                                                            	             •		 he	challenge	for	biobankers:	answering	the	message	bottom-up	with	
                                                                                                                  T
             Jonathan Horan                                                                                       their	governance	strategy
             Product	Manager	                                                                     	             •		 ransparency	to	the	public	and	patients,	avoiding	unwarranted	expectations
                                                                                                                  T
             Product Manager                                                                      	             •		 ow	to	deal	with	the	feed-back	issue?	(of	individual	results	to	participants)
                                                                                                                  H
                                                                                                  	             •		 he	traditional	view	and	the	good	reasons	for	this	view
                                                                                                                  T
                                                                                                  	             •		 hould	GWAS	change	the	traditional	view	of	(non)	individual	feed-back?
                                                                                                                  S
            BIOBANKING - wHERE IS IT HEADING?                                                     	             •		 hould	GWAS	and	international	cooperation	change	the	traditional	view	
                                                                                                                  S
                                                                                                                  of	the	promise	of	privacy?
10:10   Biobanking in 2010                                                                        	             •		 he	continuous	dialogue	with	stakeholders
                                                                                                                  T
	       •	Analysing	the	current	biobanking	landscape                                              	             •		 overnance	as	self-regulation	and	an	investment	in	trust
                                                                                                                  G
	       •	Recent	advancements	in	sample	collection	and	processing                                                      Evert-Ben van Veen
	       •	Perspective	on	future	initiatives	in	biobanking                                                              Director	
                                                                                                                       Medlawconsult
10:50   Biobanking to sustain R&D in pharma
	       •	General	aspects-purpose	and	scope
                                                                                                  15:30         Afternoon Refreshments
	       •	A-Z	perspective	of	establishing	a	biobank	                                              15:50         Security, Traceability and Interchange: information
	       •	Challenges	and	needs                                                                                  challenges for biobanks
	       	 	 Julie Corfield                                                                        	             •	Legal	and	ethical	issues	in	data	security
            R&D	Site	Biobank	Head	                                                                	             •		 aintaining	traceability	and	process	integrity	throughout	the	sample	life	cycle
                                                                                                                  M
	       	 	 Astrazeneca                                                                           	             •		 sing	IT	to	facilitating	sample	interchange	and	harmonise	associated	information
                                                                                                                  U
                                                                                                                       Jonathan Horan
11:30   Morning refreshments                                                                      	             	 	 Product	Manager	
                                                                                                                       Vitro
11:50   Biobanks - A Patient and Citizen Perspective
	       •	Broad	versus	narrow	consent                                                             16:10         Legislation & Biobanks- can they co-exist?
	       •	Feedback	of	results                                                                     	             •		mpact	of	legislation	and	HTA	regulation	on	research	(including	the	benefits)	
                                                                                                                  I
	       •	Public	and	private	sector	biobanks	(and	crossover	issues	between	them)                  	             •		 hen	is	an	HTA	licence	required	
                                                                                                                  W
	       •	Disease	specific	and	population	biobanks	and	public	engagement                          	             •		 he	different	requirements	for	use	of	tissue	from	the	living	and	tissue	
                                                                                                                  T
                                                                                                                  from	the	deceased	
	       •	Collaboration	-	harmonisation	or	standardisation?
                                                                                                  	             •		 on-consensual	use	of	DNA
                                                                                                                  N
	       •	Return	on	investment	from	a	societal	perspective
                                                                                                                       Kate Rolfvondenbaumen
             Alastair Kent                                                                                             Regulation	Manager	
             Director	                                                                                                 Human Tissue Authority
             Genetic Interest Group
                                                                                                  16:50         QA in biobanking and its importance for the
12:30   Utilising retrospective versus prospective samples                                                      generation of experimental data
        for research- the hurdles and challenges                                                  	             •		 A	of	issued	tissue/	biobanking	material	has	a	high	impact	on	the	
                                                                                                                  Q
	       •	Legal,	ethical	and	consent	requirements                                                                 potential	of	cancer	biomarker	research
	       •	Harmonisation	of	sample	handling/processing	and	QA	systems                              	             •		 A	checkpoints	in	the	process	of	tissue	collection	and	extractions	are	
                                                                                                                  Q
	       •	Clinical	information/matched	samples	-	requirements	vs	reality                                          controlled	by	using	SOPs	(standard	operation	protocols)
	       •	Cost	and	time	implications                                                              	             •		 ontrolled	specimen	quality	maximises	the	usability	of	clinical	specimens	
                                                                                                                  C
                                                                                                                  in	terms	of	the	number	of	potential	users	and	applications	and	the	
             Morag McFarlane                                                                                      quality	of	the	resulting	data
             Chief	Scientific	Officer	                                                            	             •		 he	maximum	average	quality	of	biobanking	material	is	tissue-specific
                                                                                                                  T
             Tissue Solutions                                                                     	             •		 xamples	for	techniques	well	applicable	on	low-quality	RNA:		MicroRNA	
                                                                                                                  E
                                                                                                                  and	qRT-PCR
12:50   Networking lunch                                                                          	             •		 ultiplex	PCR	–	an	approach	to	control	the	influence	of	DNA	quality	on	
                                                                                                                  M
                                                                                                                  the	quality	of	array	copy	number	data
                  wHAT ARE THE CHALLENGES?                                                        	             •		 emonstration	of	the	influence	of	DNA	quality	on	data	quality	and	how	
                                                                                                                  D
                                                                                                                  bioinformatics	deals	with	the	problem
                                                                                                                       Dr. Kristian Unger
14:10   Biobanking: an attempt at a global regulatory approach
                                                                                                                       Research	Associate	Division	of	Investigative	Science	
	       •	Typology	of	biobanks	and	their	respective	regulatory	framework	
                                                                                                                       Imperial College London
	       •		 urrent	legal	issues	in	biobanking	(privacy	issues,	ownership	rights,	
          C
          informed	consent,	etc.)	                                                                17:30         Closing remarks from the chair17:
	       •	Import	and	export	of	biobanking	materials:	a	need	for	harmonisation?
             Marc Martens                                                                         17:40         Networking drinks
             Partner	
                                                                                                                Take your discussions further and build new
             Bird & Bird LLP
                                                                                                                relationships in a relaxed and informal setting

                Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2009
Day 2
                                                                                               Biobanking Conference 2010
                                                                                      Friday 5th February 2010, London, UK


    09:30   Registration and refreshments                                                   12:30   wales Cancer Bank- Experiences of formulating an access
                                                                                                    policy and issuing samples to the research community
                                                                                            	       •		 hat	will	be	made	available?	Sample	availability	and	processing	
                                                                                                      W
    10:00   Opening address from the chair
                                                                                            	       •		 eciding	on	an	appropriate	access	policy	
                                                                                                      D
                                                                                            	       •		 echanisms	to	ensure	transparency	
                                                                                                      M
    10:10   Learn about data protection in biobanking
                                                                                            	       •		 harging	for	samples	
                                                                                                      C
    	       •		 ersonal	Data	Protection:	The	main	principles
              P                                                                             	       •		 aterial	transfer	agreements	
                                                                                                      M
    	       •		 ow	can	samples	from	clinical	studies	be	re-used	for	research?
              H                                                                             	       •		 ogistics	and	training
                                                                                                      L
    	       •		nformed	consent	in	practice:	Specificities	imposed	by	French,	Italian	and	
              I                                                                                           Dr. Alison Parry-Jones
              Spanish	authorities                                                                         Manager	
                                                                                                          Wales Cancer Bank
    	       •		 tandardising	practices:	What	level	is	possible	in	a	multinational	
              S
              pharmaceutical	company?
                                                                                            13:10   Networking lunch
                  Anne Bahr
                  R&D	Data	Privacy	Coordinator	
                                                                                            14:30   High performance DNA isolation in european
                  Sanofi Aventis
                                                                                                    biobanking projects
                                                                                            	       •		 loser	insight	in	european	biobanks
                                                                                                      C
    10:50   SIMBioMS_ - IT solutions for data collection,                                   	       •		 he	chemagic	separation	technology
                                                                                                      T
            harmonisation and analysis in large-scale biomedical
                                                                                            	       •	Automated	DNA	isolation	from	Blood,	Saliva,	Swabs
            genomics projects
                                                                                            	       •	Large	sample	volumes	up	to	10	ml
    	       •		 andling	and	combining	sample	data	(SIMS),	assays	and	measurement	
              H                                                                             	       •	High	throughput	applications	e.g.	>	1.000	samples/d
              data	from	a	wide	range	of	technologies	(AIMS),	and	for	browsing,	
              summarizing	and	annotating	its	complex	data	content	(SAIL)                                Dr. Ulla Krüppel
                                                                                                        Senior	Product	Manager	Storage	Technologies	               	              	
    	       •		 rovides	support	for	multi-partner	biomedical	data	management	from	the	
              P
                                                                                            	       	 	 Hamilton Bonaduz
              moment	of	study	design	to	the	data	analysis

    	       •		 ample	annotation	and	tracking,	sample	size	estimation	in	cross-
              S                                                                             14:50   Presentation to be announced
              collection	meta-studies,	genetic	and	molecular	data	consistency,	
              and	practical	aspects	of	data	standardisation	and	harmonisation	in	                         Dr. Martin Frey
              collaborative	discovery	projects                                                            International	Marketing	
                                                                                                          Chemagen Biopolymer-Technologie
                  Dr. Maria Krestyaninova
                  Biomedical	Informatics	Coordinator		
                                                                                            15:10   Afternoon refreshments
                  European Bioinformatics Institute

                                                                                                                    FUTURE PERSPECTIVES
    11:30   Morning refreshments

                                                                                            15:30   Commercialisation challenges
                            RECENT CASE STUDIES                                             	       •		 nalysing	quality	and	logistic	issues	
                                                                                                      A
                                                                                            	       •		 iscussing	regulatory	issues	related	to	commercialisation	of	stem	cells	
                                                                                                      D
                                                                                                      from	biobanks
    11:50   The infectious diseases biobank at King’s                                                     Dr. Michael D. Leek
            College London: Facilitating translational                                                    Vice	President	
            research of pathogens                                                                         The Weinberg Group

    	       •		 ocal	need	for	the	resource
              L
                                                                                            16:10   Public attitudes to tissue and organ donation
    	       •		 ioBank	organisation	and	operation
              B                                                                             	       •		 ethods	of	engaging	the	public	on	complex	and	sensitive	issues
                                                                                                      M
    	       •		 utcomes
              O                                                                             	       •		 esults	from	several	OL	research	projects	relating	to	tissue	and		
                                                                                                      R
                                                                                                      organ	donation
    	       •		 uture	challenges
              F
                                                                                                          Becky Seale
                  Dr. John Cason
                                                                                                          Consultant	
                  Senior	(Non-Clinical)	Lecturer	in	Virology	
                                                                                                          Opinion Leader
                  King’s College London School of Medicine

                                                                                            16:50   Chair’s closing remarks and end of conference

*	Invited
Registration Form
                                                                                                                     Biobanking Conference 2010
                                                                                                             4th - 5th February 2010, London, UK


For multiple bookings
Photocopy	this	form			          	              	               	          	               Conf.	code	TA           Biobanking
                                                                                                                  Conference 2010
Standard Prices
Conference only                                    Fee: £1299      VAT: £194.85      Total: £1493.85              4th - 5th February 2010
Academic rate                                      Fee: £899       VAT: £134.85      Total: £1033.85              Location:		 arls	Court	Conference	Centre
                                                                                                                            E
                                                                                                                  Address:		
                                                                                                                  Warwick	Road
Promotional Literature Distribution                                                                               London
Distribution of your company’s promotional literature to all conference attendees                                 SW5	9TA
                                                   Fee: £999       VAT: £149.85      Total: £1148.85


Details
                                                                                                              How to book
Forename:	                                         Surname:                                                   Email:	conferences@visiongainglobal.com	
                                                                                                              Web:	http://www.visiongain.com/biobanking
Job	Title:	                                        Company:                                                   UK Office:
                                                                                                              Tel: 	+44(0)	20	7336	6100
Main	Switchboard	Number:                                                                                      Fax:	+44(0)	20	7549	9932	
                                                                                                              Visiongain	Ltd
Address:                                                                                                      BSG	House
                                                                                                              226-236	City	Road	
                                                                                                              London
                                                                                                              EC1V	2QY
                                                                                                              UK
Country:	                                          Postcode:
                                                                                                              General information
                                                                                                              Venue:	Earls	Court	Conference	Centre,	Warwick	Road,	London,	SW5	9TA.		
Phone:	                                            Fax:                                                       From	West	Brompton	station,	the	venue	is	directly	opposite	the	station	exit.	Walk	to	the	left-hand	side.	
                                                                                                              From	Earl’s	Court	station,	exit	through	the	Warwick	Road	exit	and	walk	down	the	left-hand	side	of	the	
Email:	                                                                                                       building.
                                                                                                              Payment terms:	Visiongain	require	the	full	amount	to	be	paid	before	the	conference.	Visiongain	
Signature:                                                                                                    Ltd	may	refuse	entry	to	delegates	who	have	not	paid	their	invoice	in	full.	A	credit	card	guarantee	may	
                                                                                                              be	requested	if	payment	has	not	been	received	in	full	before	the	event.	Visiongain	Ltd	reserves	the	
I	confirm	that	I	have	read	and	agree	to	the	terms	and	conditions	of	booking                                   right	to	charge	interest	on	unpaid	invoices.
                                                                                                              Substitutions/name changes or cancellations: There	is	a	50%	liability	on	all	bookings	once	
                                                                                                              made,	whether	by	post,	fax,	email	or	web.	There	is	a	no	refund	policy	for	cancellations	received	on	
Methods of payment                                                                                            or	after	one	month	before	the	start	of	the	event.	Should	you	decide	to	cancel	after	this	date,	the	
                                                                                                              full	invoice	must	be	paid.	Conference	notes	will	then	be	sent	to	you.	Unfortunately,	we	are	unable	
Payment	must	be	made	in	sterling
                                                                                                              to	transfer	places	between	conferences	and	executive	briefings.	However,	if	you	cannot	attend	the	
By Mail: Complete	and	return	your	signed	registration	form	together	with	your	cheque	payable	                 conference,	you	may	make	a	substitution/name	change	at	any	time,	as	long	as	we	are	informed	in	
                                                                                                              writing	by	email,	fax	or	post.	Name	changes	and	substitutions	must	be	from	the	same	company	or	
to	Visiongain	Ltd	and	send	to:	visiongain	Ltd,	BSG	House,	226-236	City	Road,	London,	EC1V	2QY,	UK             organisation	and	are	not	transferable	between	countries.
By Fax: Complete	and	fax	your	signed	registration	form	with	your	credit	card	details		                        Invoice alterations:	There	will	be	an	administration	charge	of	£50	for	any	changes	to	an	invoice,	
                                                                                                              excluding	 substitutions/name	 changes,	 requested	 by	 the	 customer.	 This	 will	 be	 charged	 to	 the	
to	+44	(0)	20	7549	9932                                                                                       customer	by	credit	card	prior	to	the	changes	being	made.
By Phone:	Call	us	on	+44	(0)	20	7336	6100	with	your	credit	card	details	                                      Indemnity:	 Visiongain	 Ltd	 reserves	 the	 right	 to	 make	 alterations	 to	 the	 conference/executive	
                                                                                                              briefing	content,	timing,	speakers	or	venue	without	notice.	The	event	may	be	postponed	or	cancelled	
By Credit Card:	Fill	in	your	card	details	below	and	fax	back	to	+44	(0)	20	7549	9932                          due	to	unforeseen	events	beyond	the	control	of	visiongain	Ltd.	If	such	a	situation	arises,	we	will	try	
                                                                                                              to	reschedule	the	event.	However,	visiongain	Ltd	cannot	be	held	responsible	for	any	cost,	damage	or	
By Bank Transfer:                                                                                             expenses,	which	may	be	incurred	by	the	customer	as	a	consequence	of	the	event	being	postponed	or	
Visiongain	Ltd	                                                                       A/C:	visiongain	Ltd	    cancelled.	We	therefore	strongly	advise	all	our	conference	clients	to	take	out	insurance	to	cover	the	
                                                                                                              cost	of	the	registration,	travel	and	expenses.
Barclays	Bank	                                                                       Sort	Code:	20-71-64	
                                                                                                              Data Protection:	 Visiongain	 Ltd	 gathers	 and	 manages	 data	 in	 accordance	 with	 the	 Data	
Piccadilly	Branch	                                                                Account	No:	6038	7118	      Protection	Act	1988.	Your	personal	information	contained	in	this	form	may	be	used	to	update	you	on	
48	Regent	Street	                                                                 Swift	Code:	BARC	GB22	
                                                                                                       	      visiongain	Ltd	products	and	services	via	post,	telephone,	fax	or	email,	unless	you	state	otherwise.	We	
                                                                                                              may	also	share	your	data	with	external	companies	offering	complementary	products	or	services.	If	you	
London,	W1B	5RA	                                                   IBAN:	GB80	BARC	20716460387118             wish	for	your	details	to	be	amended,	suppressed	or	not	passed	on	to	any	external	third	party,	please	
                                                                                                              send	your	request	to	the	Database	Manager,	visiongain	Ltd,	BSG	House,	226-236	City	Road,	London,	
Please debit my credit card:
                                                                                                              EC1V	2QY.	Alternatively,	you	can	visit	our	website	at	www.visiongain.com	and	amend	your	details.	
   	Access	      	MasterCard	       	Visa	   	American	Express                                                Please	allow	approximately	30	days	for	your	removal	or	update	request	to	be	applied	to	our	database.	
                                                                                                              Following	your	removal	or	update	request,	you	may	receive	additional	pieces	of	communication	from	
                                                                                                              visiongain	Ltd	during	the	transitional	period,	whilst	the	changes	are	coming	into	effect.
                                                                                                              Fee: The	conference	fee	includes	lunch,	refreshments	and	conference	papers	provided	on	the	day.	
Card	number:
                                                                                                              This	 fee	 does	 not	 include	 travel,	 hotel	 accommodation,	 transfers	 or	 insurance,	 (which	 we	 strongly	
                                                                                                              recommend	you	obtain).
                                                                                                              VAT: VAT	will	be	charged	at	the	local	rate	on	each	conference.	Delegates	may	be	able	to	recover	VAT	
Expiry	Date:	                                                                                                 incurred	by	contacting	Eurocash	Corporation	plc	+44	(0)	1273	325000,	eurocash@eurocashvat.com.	
                                                                                                              Eurocash	specialise	in	recovering	cross-border	VAT.
Security	number	(last	3	digits	on	back	of	credit	card):                                                       How we will contact you: Visiongain	Ltd’s	preferred	method	of	communication	is	by	email	and	
                                                                                                              phone.	Please	ensure	that	you	complete	the	registration	form	in	full	so	that	we	can	contact	you.
Signature:
                                                                                                              Unable to attend
Cardholder’s	name:                                                                                            Obviously	nothing	compares	to	being	there	but	you	need	not	miss	out.	Simply	tick	the	box	and	send	
                                                                                                              with	your	payment.	You	will	receive	your	copy	of	the	event	CD	Rom	two	weeks	after	the	event.
                                                                                                              Yes, please send me a copy of the CD for             Price£550       VAT:£82.50        Total:£632.50
News updates
                                                                                                              Office use only
Please	tick	if	you	do	not	want	to	receive	email	news	updates	in	the	future




                                                                       www.visiongain.com/biobanking

Mais conteúdo relacionado

Destaque

Lilienfelder SPÖ Rundschau, Ausgabe 1 2011
Lilienfelder SPÖ Rundschau, Ausgabe 1 2011Lilienfelder SPÖ Rundschau, Ausgabe 1 2011
Lilienfelder SPÖ Rundschau, Ausgabe 1 2011Christoph Freilinger
 
Clase 2 configurar blog con blogger
Clase 2 configurar blog con bloggerClase 2 configurar blog con blogger
Clase 2 configurar blog con bloggerMiryam Illangua
 
Programa smagua 2014 reglamentación en contacto agua potable
Programa smagua 2014 reglamentación en contacto agua potablePrograma smagua 2014 reglamentación en contacto agua potable
Programa smagua 2014 reglamentación en contacto agua potablerodolfovegascalderon
 
Quarterly Review of the Software & Internet Sector - Q1 2016
Quarterly Review of the Software & Internet Sector - Q1 2016Quarterly Review of the Software & Internet Sector - Q1 2016
Quarterly Review of the Software & Internet Sector - Q1 2016Mark Weisman
 
BARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPAL
BARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPALBARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPAL
BARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPALManel Cantos
 
Catalogue aurile 2
Catalogue aurile 2Catalogue aurile 2
Catalogue aurile 2ISABERNE
 
ECARP for ORA
ECARP for ORAECARP for ORA
ECARP for ORAMoore Dsl
 
Boss cdsm amp effects processor gt 100
Boss cdsm amp effects processor gt 100Boss cdsm amp effects processor gt 100
Boss cdsm amp effects processor gt 100cromicom
 
101022 arktik session energy camp hh
101022   arktik session energy camp hh101022   arktik session energy camp hh
101022 arktik session energy camp hhNina
 
Social Media workshop for A&N Media
Social Media workshop for A&N MediaSocial Media workshop for A&N Media
Social Media workshop for A&N MediaRichard Sedley
 
Carreras universitarias
Carreras universitariasCarreras universitarias
Carreras universitariasemea2628
 
Portoni garage basculanti
Portoni garage basculantiPortoni garage basculanti
Portoni garage basculantiBusinessWeb srl
 
Mutualia jesus dalmau
Mutualia jesus dalmauMutualia jesus dalmau
Mutualia jesus dalmauSEMATEC
 
Perú “Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT
Perú“Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT Perú“Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT
Perú “Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT FitelPeru
 

Destaque (20)

Lilienfelder SPÖ Rundschau, Ausgabe 1 2011
Lilienfelder SPÖ Rundschau, Ausgabe 1 2011Lilienfelder SPÖ Rundschau, Ausgabe 1 2011
Lilienfelder SPÖ Rundschau, Ausgabe 1 2011
 
Clase 2 configurar blog con blogger
Clase 2 configurar blog con bloggerClase 2 configurar blog con blogger
Clase 2 configurar blog con blogger
 
Programa smagua 2014 reglamentación en contacto agua potable
Programa smagua 2014 reglamentación en contacto agua potablePrograma smagua 2014 reglamentación en contacto agua potable
Programa smagua 2014 reglamentación en contacto agua potable
 
Quarterly Review of the Software & Internet Sector - Q1 2016
Quarterly Review of the Software & Internet Sector - Q1 2016Quarterly Review of the Software & Internet Sector - Q1 2016
Quarterly Review of the Software & Internet Sector - Q1 2016
 
BARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPAL
BARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPALBARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPAL
BARCELONA 71 - CIUTAT VELLA 1 - DISTRICTE MUNICIPAL
 
Ivan
IvanIvan
Ivan
 
Catalogue aurile 2
Catalogue aurile 2Catalogue aurile 2
Catalogue aurile 2
 
Lista de asistencia primer s.
Lista de asistencia primer s.Lista de asistencia primer s.
Lista de asistencia primer s.
 
The Sun Cloud
The Sun CloudThe Sun Cloud
The Sun Cloud
 
ECARP for ORA
ECARP for ORAECARP for ORA
ECARP for ORA
 
Boss cdsm amp effects processor gt 100
Boss cdsm amp effects processor gt 100Boss cdsm amp effects processor gt 100
Boss cdsm amp effects processor gt 100
 
101022 arktik session energy camp hh
101022   arktik session energy camp hh101022   arktik session energy camp hh
101022 arktik session energy camp hh
 
Proyecto REDCNL (2/2)
Proyecto REDCNL (2/2)Proyecto REDCNL (2/2)
Proyecto REDCNL (2/2)
 
Social Media workshop for A&N Media
Social Media workshop for A&N MediaSocial Media workshop for A&N Media
Social Media workshop for A&N Media
 
Carreras universitarias
Carreras universitariasCarreras universitarias
Carreras universitarias
 
CV
CVCV
CV
 
Portoni garage basculanti
Portoni garage basculantiPortoni garage basculanti
Portoni garage basculanti
 
Mutualia jesus dalmau
Mutualia jesus dalmauMutualia jesus dalmau
Mutualia jesus dalmau
 
Perú “Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT
Perú“Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT Perú“Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT
Perú “Small Cells” - ESTEBAN DIAZGRANADOS ALCATEL LUCENT
 
The Jet Set
The Jet SetThe Jet Set
The Jet Set
 

Semelhante a Biobanking 2010 Ta

Biobanking americas (2011)
Biobanking americas (2011)Biobanking americas (2011)
Biobanking americas (2011)Pranita Nangia
 
Bioinformatics Conference 2010
Bioinformatics Conference 2010Bioinformatics Conference 2010
Bioinformatics Conference 2010Pranita Nangia
 
7th Annual Biosimilars (2010)
7th Annual Biosimilars (2010)7th Annual Biosimilars (2010)
7th Annual Biosimilars (2010)jaayboy69
 
4th Annual Biomarkers (2011) Pp
4th Annual Biomarkers (2011) Pp4th Annual Biomarkers (2011) Pp
4th Annual Biomarkers (2011) PpPiyush Patel
 
Biobanking Americas (2010)
Biobanking Americas (2010)Biobanking Americas (2010)
Biobanking Americas (2010)jaayboy69
 
6th Annual Biosimilars 2010 (Usa)
6th Annual Biosimilars 2010 (Usa)6th Annual Biosimilars 2010 (Usa)
6th Annual Biosimilars 2010 (Usa)Coneyskuhl
 
5th Annual Recombinant Antibodies (2012) Pp
5th Annual Recombinant Antibodies (2012) Pp5th Annual Recombinant Antibodies (2012) Pp
5th Annual Recombinant Antibodies (2012) PpPiyush Patel
 
3rd Annual Packaging And Labelling Congress (2010) Ts
3rd Annual Packaging And Labelling Congress (2010) Ts3rd Annual Packaging And Labelling Congress (2010) Ts
3rd Annual Packaging And Labelling Congress (2010) Tstatisalla
 
4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) PpPiyush Patel
 
Aesthetics and anti ageing (2011)
Aesthetics and anti ageing (2011)Aesthetics and anti ageing (2011)
Aesthetics and anti ageing (2011)Pranita Nangia
 
4th Annual Pharmaceutical Plm (2010) Ta
4th Annual Pharmaceutical Plm (2010) Ta4th Annual Pharmaceutical Plm (2010) Ta
4th Annual Pharmaceutical Plm (2010) Tatatisalla
 
5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) Pp5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) PpPiyush Patel
 
11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)shad121
 
Clinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) FbClinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) FbFateja
 
Vaccine research & innovation
Vaccine research &  innovationVaccine research &  innovation
Vaccine research & innovationjaayboy69
 
5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Ts5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Tstatisalla
 
5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) Pp5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) PpPiyush Patel
 
Biobanking 2010 Brochure
Biobanking 2010 BrochureBiobanking 2010 Brochure
Biobanking 2010 Brochurerohanshams
 
6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)Pranita Nangia
 

Semelhante a Biobanking 2010 Ta (20)

Biobanking americas (2011)
Biobanking americas (2011)Biobanking americas (2011)
Biobanking americas (2011)
 
Biobanking 2011
Biobanking 2011Biobanking 2011
Biobanking 2011
 
Bioinformatics Conference 2010
Bioinformatics Conference 2010Bioinformatics Conference 2010
Bioinformatics Conference 2010
 
7th Annual Biosimilars (2010)
7th Annual Biosimilars (2010)7th Annual Biosimilars (2010)
7th Annual Biosimilars (2010)
 
4th Annual Biomarkers (2011) Pp
4th Annual Biomarkers (2011) Pp4th Annual Biomarkers (2011) Pp
4th Annual Biomarkers (2011) Pp
 
Biobanking Americas (2010)
Biobanking Americas (2010)Biobanking Americas (2010)
Biobanking Americas (2010)
 
6th Annual Biosimilars 2010 (Usa)
6th Annual Biosimilars 2010 (Usa)6th Annual Biosimilars 2010 (Usa)
6th Annual Biosimilars 2010 (Usa)
 
5th Annual Recombinant Antibodies (2012) Pp
5th Annual Recombinant Antibodies (2012) Pp5th Annual Recombinant Antibodies (2012) Pp
5th Annual Recombinant Antibodies (2012) Pp
 
3rd Annual Packaging And Labelling Congress (2010) Ts
3rd Annual Packaging And Labelling Congress (2010) Ts3rd Annual Packaging And Labelling Congress (2010) Ts
3rd Annual Packaging And Labelling Congress (2010) Ts
 
4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp4th Pre Filled Syringes (2011) Pp
4th Pre Filled Syringes (2011) Pp
 
Aesthetics and anti ageing (2011)
Aesthetics and anti ageing (2011)Aesthetics and anti ageing (2011)
Aesthetics and anti ageing (2011)
 
4th Annual Pharmaceutical Plm (2010) Ta
4th Annual Pharmaceutical Plm (2010) Ta4th Annual Pharmaceutical Plm (2010) Ta
4th Annual Pharmaceutical Plm (2010) Ta
 
5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) Pp5th Annual Stability Testing (2011) Pp
5th Annual Stability Testing (2011) Pp
 
11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)11th Annual Biosimilars Uk (2012)
11th Annual Biosimilars Uk (2012)
 
Clinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) FbClinical Trial Logistics & Supply (2011) Fb
Clinical Trial Logistics & Supply (2011) Fb
 
Vaccine research & innovation
Vaccine research &  innovationVaccine research &  innovation
Vaccine research & innovation
 
5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Ts5th Annual Pharmacovigilance (2010) Ts
5th Annual Pharmacovigilance (2010) Ts
 
5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) Pp5th Annual Product Lifecycle Management (2012) Pp
5th Annual Product Lifecycle Management (2012) Pp
 
Biobanking 2010 Brochure
Biobanking 2010 BrochureBiobanking 2010 Brochure
Biobanking 2010 Brochure
 
6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)6th annual pharmacovigilance conference (2011)
6th annual pharmacovigilance conference (2011)
 

Biobanking 2010 Ta

  • 1. Biobanking Conference 2010 Analysing the trends and understanding the complexities of biobanking 4th - 5th February 2010, Earls Court Conference Centre, London, UK BOOK NOW! Key Speakers Julie Corfield, R&D Site Biobank Head, Astrazeneca Anne Bahr, R&D Data Privacy Coordinator, Sanofi-Aventis Dr. Maria Krestyaninova, Biomedical Informatics Coordinator, European Bioinformatics Institute Dr. Kristian Unger, Research Associate Division of Investigative Science, Imperial College London Kate Rolfvondenbaumen, Regulation Manager, Human Tissue Authority Alastair Kent, Director, Genetic Interest Group Dr. Alison Parry-Jones, Manager, Wales Cancer Bank Marc Martens, Partner, Bird & Bird LLP Morag McFarlane, Chief Scientific Officer, Tissue Solutions Dr. John Cason, Senior (Non-Clinical) Lecturer in Virology, King’s College London School of Medicine Dr. Michael D. Leek, Vice President, The Weinberg Group Dr. Martin Frey, Senior Product Manager Storage Technologies, Hamilton Bonaduz Dr. Ulla Krüppel, International Marketing, Chemagen Biopolymer-Technologie Jonathan Horan, Product Manager, Vitro Silver Sponsor Associate Sponsors R Driving the Industry Forward | www.futurepharmaus.com Organised By Media Partners To Book Call: +44 (0) 20 7336 6100 | www.visiongain.com/biobanking
  • 2. Conference Introduction Biobanking Conference 2010 4th - 5th February 2010, London, UK Silver Sponsor: Dear Colleague, NEXUS Biosystems is a worldwide developer of enabling technologies and automation systems for life science research. Products include the Universal iobanking is changing rapidly. Biobanks are playing a vital role in the today’s B Store, Universal LabStore, and Universal BioStore family of automated -20C research and development in the fields of drug discovery and bioscience. The and -80C sample storage and retrieval systems, the Aurora Biotechnologies line of high performance biobanking sector has expanded at a tremendous rate in recent years, and has microplates, and the XPeel, a high throughput plate seal removal system. also been facing many legal, financial, ethical, scientific challenges. For further information please visit: www.nexusbio.com isiongain is happy to announce its inaugural Biobanking Conference which V Associate Sponsors: will examine major trends in the biobanking industry and its changing scope. By attending Visiongain’s Biobanking conference delegates will gain an in-depth understanding of the emerging opportunities, challenges and advancements made in the field of biobanking. For further information please visit www.bio-e-bank.com Why Attend? For further information please visit www.thermofisher.com Key benefits For almost 50 years HAMILTON products have successfully served researchers in laboratories all over the world. A long history of successful products began in 1947 with • Assess the increasing need for developing biobanks the development of the MICROLAB® syringe by the company’s founder. The commitment R to precision, accuracy and quality has earned HAMILTON high customer satisfaction. With • Understand the ethical and regulatory issues the MICROLAB® STAR workstation, HAMILTON has again achieved technological leadership. In addition to this open DNA extraction platform, HAMILTON offers modular automated storage solutions with the ASM -20°C • Implement strategies to develop a cost-effective biobank system and the SAM -80°C. From sample preparation to storage: One solution from the technology leader. • Examine the importance of patient involvement in biobank projects For further information please visit www.hamiltonrobotics.com • Learn about data protection and quality management in biobanking Media Partners: PharmiWeb.com is the leading industry-sponsored portal for the • Discuss most acute and challenging scientific and policy related matters pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, PharmiWeb.com provides dynamic real-time news, features, • eize this opportunity to network with leaders from pharma-biotech, S events listings and international jobs to industry professionals across Europe and the US. healthcare and regulatory agencies For further information please email: corporate@pharmiweb.com BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. I look forward to meeting you at the conference It is based and located in Warsaw, Poland. Biotechnology World was Best regards founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to Pranita Nangia global biotechnology, pharmaceutical and life science activities. Conference Producer For further information please visit www.biotechnology-europe.com Future Pharmaceuticals has forged powerful relationships with key Driving the Industry Forward | www.futurepharmaus.com industry leaders to provide a platform for successful brand recognition, and for senior decision-makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top Who should attend? pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging VPs, Directors, Heads, Managers of: the gap between the industries’ top issues and the solutions top-tier vendors can provide. • Biobanks For further information please visit: www.futurepharmaus.com • Tissue bank InPharm is the online platform for exclusive pharmaceutical news, • Biorepository comment, contracts, services, jobs and events and is home to • Molecular Diagnostics InPharmjobs.com, Pharmafile and Pharmafocus. • Clinical Genetics, Pathology • Histopathology For further information please visit: www.In-Pharm.com • Medical Genomics ‘Pharma Connections Worldwide® is the leading professional • Non-clinical Biosample business networking website focused in the Pharmaceutical, • Data Privacy Office Biotechnology and Life Sciences research industry. Our goal is to • Health Science Policy provide a conduit for delivery of premiere content coupled with the right clientele in order to • Scientific and Quality facilitate business development opportunities among industry professionals responsible for • Toxicology, Clinical chemistry making key decisions in a global marketplace. ‘ • Laboratory and Inventory For further information please visit: www.pharmaconnections.com • R&D • Quality Control • Pharmacogenomics • Procurement and Strategic Sourcing Sponsorship and exhibition opportunities: • Strategic Outsourcing This event offers a unique opportunity to meet and do business with some • Clinical Research • Translational Medicine of the key players in the pharmaceutical and biotech industries. If you have a • Personalized Medicine, service or product to promote, you can do so at this event by: • Bioanalytical Chemistry • Hosting a networking drinks reception • Clinical trials and Non-clinical R & D • Pharmacogenomics • Taking an exhibition space at the conference • Proteomics • Advertising in the delegate documentation pack • Personalised medicine • Providing branded bags, pens, gifts, etc. • Business development • Strategic alliances If you would like more information on the range of sponsorship or exhibition possibilities for visiongain's Biobanking Conference 2010, please contact us: Others: Christopher Clegg, +44 (0)20 7549 9943 • Consultants& Academics christopher.clegg@visiongainglobal.com • Regulatory bodies • Researchers Ronald Magali, +44 (0)20 7549 9934 ronald.magali@visiongainglobal.com
  • 3. Day 1 Biobanking Conference 2010 Thursday 4th February 2010, London, UK 09:30 Registration and refreshments 14:50 Challenges for the governance of biobanks • he mixed message of regulatory bodies: ‘dangers’ and ‘profits’ T 10:00 Opening address from the chair • he challenge for biobankers: answering the message bottom-up with T Jonathan Horan their governance strategy Product Manager • ransparency to the public and patients, avoiding unwarranted expectations T Product Manager • ow to deal with the feed-back issue? (of individual results to participants) H • he traditional view and the good reasons for this view T • hould GWAS change the traditional view of (non) individual feed-back? S BIOBANKING - wHERE IS IT HEADING? • hould GWAS and international cooperation change the traditional view S of the promise of privacy? 10:10 Biobanking in 2010 • he continuous dialogue with stakeholders T • Analysing the current biobanking landscape • overnance as self-regulation and an investment in trust G • Recent advancements in sample collection and processing Evert-Ben van Veen • Perspective on future initiatives in biobanking Director Medlawconsult 10:50 Biobanking to sustain R&D in pharma • General aspects-purpose and scope 15:30 Afternoon Refreshments • A-Z perspective of establishing a biobank 15:50 Security, Traceability and Interchange: information • Challenges and needs challenges for biobanks Julie Corfield • Legal and ethical issues in data security R&D Site Biobank Head • aintaining traceability and process integrity throughout the sample life cycle M Astrazeneca • sing IT to facilitating sample interchange and harmonise associated information U Jonathan Horan 11:30 Morning refreshments Product Manager Vitro 11:50 Biobanks - A Patient and Citizen Perspective • Broad versus narrow consent 16:10 Legislation & Biobanks- can they co-exist? • Feedback of results • mpact of legislation and HTA regulation on research (including the benefits) I • Public and private sector biobanks (and crossover issues between them) • hen is an HTA licence required W • Disease specific and population biobanks and public engagement • he different requirements for use of tissue from the living and tissue T from the deceased • Collaboration - harmonisation or standardisation? • on-consensual use of DNA N • Return on investment from a societal perspective Kate Rolfvondenbaumen Alastair Kent Regulation Manager Director Human Tissue Authority Genetic Interest Group 16:50 QA in biobanking and its importance for the 12:30 Utilising retrospective versus prospective samples generation of experimental data for research- the hurdles and challenges • A of issued tissue/ biobanking material has a high impact on the Q • Legal, ethical and consent requirements potential of cancer biomarker research • Harmonisation of sample handling/processing and QA systems • A checkpoints in the process of tissue collection and extractions are Q • Clinical information/matched samples - requirements vs reality controlled by using SOPs (standard operation protocols) • Cost and time implications • ontrolled specimen quality maximises the usability of clinical specimens C in terms of the number of potential users and applications and the Morag McFarlane quality of the resulting data Chief Scientific Officer • he maximum average quality of biobanking material is tissue-specific T Tissue Solutions • xamples for techniques well applicable on low-quality RNA: MicroRNA E and qRT-PCR 12:50 Networking lunch • ultiplex PCR – an approach to control the influence of DNA quality on M the quality of array copy number data wHAT ARE THE CHALLENGES? • emonstration of the influence of DNA quality on data quality and how D bioinformatics deals with the problem Dr. Kristian Unger 14:10 Biobanking: an attempt at a global regulatory approach Research Associate Division of Investigative Science • Typology of biobanks and their respective regulatory framework Imperial College London • urrent legal issues in biobanking (privacy issues, ownership rights, C informed consent, etc.) 17:30 Closing remarks from the chair17: • Import and export of biobanking materials: a need for harmonisation? Marc Martens 17:40 Networking drinks Partner Take your discussions further and build new Bird & Bird LLP relationships in a relaxed and informal setting Due to unforeseen circumstances the programme may change and visiongain reserves the right to alter the venue and/or speakers c Copyright visiongain Ltd, 2009
  • 4. Day 2 Biobanking Conference 2010 Friday 5th February 2010, London, UK 09:30 Registration and refreshments 12:30 wales Cancer Bank- Experiences of formulating an access policy and issuing samples to the research community • hat will be made available? Sample availability and processing W 10:00 Opening address from the chair • eciding on an appropriate access policy D • echanisms to ensure transparency M 10:10 Learn about data protection in biobanking • harging for samples C • ersonal Data Protection: The main principles P • aterial transfer agreements M • ow can samples from clinical studies be re-used for research? H • ogistics and training L • nformed consent in practice: Specificities imposed by French, Italian and I Dr. Alison Parry-Jones Spanish authorities Manager Wales Cancer Bank • tandardising practices: What level is possible in a multinational S pharmaceutical company? 13:10 Networking lunch Anne Bahr R&D Data Privacy Coordinator 14:30 High performance DNA isolation in european Sanofi Aventis biobanking projects • loser insight in european biobanks C 10:50 SIMBioMS_ - IT solutions for data collection, • he chemagic separation technology T harmonisation and analysis in large-scale biomedical • Automated DNA isolation from Blood, Saliva, Swabs genomics projects • Large sample volumes up to 10 ml • andling and combining sample data (SIMS), assays and measurement H • High throughput applications e.g. > 1.000 samples/d data from a wide range of technologies (AIMS), and for browsing, summarizing and annotating its complex data content (SAIL) Dr. Ulla Krüppel Senior Product Manager Storage Technologies • rovides support for multi-partner biomedical data management from the P Hamilton Bonaduz moment of study design to the data analysis • ample annotation and tracking, sample size estimation in cross- S 14:50 Presentation to be announced collection meta-studies, genetic and molecular data consistency, and practical aspects of data standardisation and harmonisation in Dr. Martin Frey collaborative discovery projects International Marketing Chemagen Biopolymer-Technologie Dr. Maria Krestyaninova Biomedical Informatics Coordinator 15:10 Afternoon refreshments European Bioinformatics Institute FUTURE PERSPECTIVES 11:30 Morning refreshments 15:30 Commercialisation challenges RECENT CASE STUDIES • nalysing quality and logistic issues A • iscussing regulatory issues related to commercialisation of stem cells D from biobanks 11:50 The infectious diseases biobank at King’s Dr. Michael D. Leek College London: Facilitating translational Vice President research of pathogens The Weinberg Group • ocal need for the resource L 16:10 Public attitudes to tissue and organ donation • ioBank organisation and operation B • ethods of engaging the public on complex and sensitive issues M • utcomes O • esults from several OL research projects relating to tissue and R organ donation • uture challenges F Becky Seale Dr. John Cason Consultant Senior (Non-Clinical) Lecturer in Virology Opinion Leader King’s College London School of Medicine 16:50 Chair’s closing remarks and end of conference * Invited
  • 5. Registration Form Biobanking Conference 2010 4th - 5th February 2010, London, UK For multiple bookings Photocopy this form Conf. code TA Biobanking Conference 2010 Standard Prices Conference only Fee: £1299 VAT: £194.85 Total: £1493.85 4th - 5th February 2010 Academic rate Fee: £899 VAT: £134.85 Total: £1033.85 Location: arls Court Conference Centre E Address: Warwick Road Promotional Literature Distribution London Distribution of your company’s promotional literature to all conference attendees SW5 9TA Fee: £999 VAT: £149.85 Total: £1148.85 Details How to book Forename: Surname: Email: conferences@visiongainglobal.com Web: http://www.visiongain.com/biobanking Job Title: Company: UK Office: Tel: +44(0) 20 7336 6100 Main Switchboard Number: Fax: +44(0) 20 7549 9932 Visiongain Ltd Address: BSG House 226-236 City Road London EC1V 2QY UK Country: Postcode: General information Venue: Earls Court Conference Centre, Warwick Road, London, SW5 9TA. Phone: Fax: From West Brompton station, the venue is directly opposite the station exit. Walk to the left-hand side. From Earl’s Court station, exit through the Warwick Road exit and walk down the left-hand side of the Email: building. Payment terms: Visiongain require the full amount to be paid before the conference. Visiongain Signature: Ltd may refuse entry to delegates who have not paid their invoice in full. A credit card guarantee may be requested if payment has not been received in full before the event. Visiongain Ltd reserves the I confirm that I have read and agree to the terms and conditions of booking right to charge interest on unpaid invoices. Substitutions/name changes or cancellations: There is a 50% liability on all bookings once made, whether by post, fax, email or web. There is a no refund policy for cancellations received on Methods of payment or after one month before the start of the event. Should you decide to cancel after this date, the full invoice must be paid. Conference notes will then be sent to you. Unfortunately, we are unable Payment must be made in sterling to transfer places between conferences and executive briefings. However, if you cannot attend the By Mail: Complete and return your signed registration form together with your cheque payable conference, you may make a substitution/name change at any time, as long as we are informed in writing by email, fax or post. Name changes and substitutions must be from the same company or to Visiongain Ltd and send to: visiongain Ltd, BSG House, 226-236 City Road, London, EC1V 2QY, UK organisation and are not transferable between countries. By Fax: Complete and fax your signed registration form with your credit card details Invoice alterations: There will be an administration charge of £50 for any changes to an invoice, excluding substitutions/name changes, requested by the customer. This will be charged to the to +44 (0) 20 7549 9932 customer by credit card prior to the changes being made. By Phone: Call us on +44 (0) 20 7336 6100 with your credit card details Indemnity: Visiongain Ltd reserves the right to make alterations to the conference/executive briefing content, timing, speakers or venue without notice. The event may be postponed or cancelled By Credit Card: Fill in your card details below and fax back to +44 (0) 20 7549 9932 due to unforeseen events beyond the control of visiongain Ltd. If such a situation arises, we will try to reschedule the event. However, visiongain Ltd cannot be held responsible for any cost, damage or By Bank Transfer: expenses, which may be incurred by the customer as a consequence of the event being postponed or Visiongain Ltd A/C: visiongain Ltd cancelled. We therefore strongly advise all our conference clients to take out insurance to cover the cost of the registration, travel and expenses. Barclays Bank Sort Code: 20-71-64 Data Protection: Visiongain Ltd gathers and manages data in accordance with the Data Piccadilly Branch Account No: 6038 7118 Protection Act 1988. Your personal information contained in this form may be used to update you on 48 Regent Street Swift Code: BARC GB22 visiongain Ltd products and services via post, telephone, fax or email, unless you state otherwise. We may also share your data with external companies offering complementary products or services. If you London, W1B 5RA IBAN: GB80 BARC 20716460387118 wish for your details to be amended, suppressed or not passed on to any external third party, please send your request to the Database Manager, visiongain Ltd, BSG House, 226-236 City Road, London, Please debit my credit card: EC1V 2QY. Alternatively, you can visit our website at www.visiongain.com and amend your details. Access MasterCard Visa American Express Please allow approximately 30 days for your removal or update request to be applied to our database. Following your removal or update request, you may receive additional pieces of communication from visiongain Ltd during the transitional period, whilst the changes are coming into effect. Fee: The conference fee includes lunch, refreshments and conference papers provided on the day. Card number: This fee does not include travel, hotel accommodation, transfers or insurance, (which we strongly recommend you obtain). VAT: VAT will be charged at the local rate on each conference. Delegates may be able to recover VAT Expiry Date: incurred by contacting Eurocash Corporation plc +44 (0) 1273 325000, eurocash@eurocashvat.com. Eurocash specialise in recovering cross-border VAT. Security number (last 3 digits on back of credit card): How we will contact you: Visiongain Ltd’s preferred method of communication is by email and phone. Please ensure that you complete the registration form in full so that we can contact you. Signature: Unable to attend Cardholder’s name: Obviously nothing compares to being there but you need not miss out. Simply tick the box and send with your payment. You will receive your copy of the event CD Rom two weeks after the event. Yes, please send me a copy of the CD for Price£550 VAT:£82.50 Total:£632.50 News updates Office use only Please tick if you do not want to receive email news updates in the future www.visiongain.com/biobanking